专栏名称: 毕凯今选
由毕凯医药为您每周跟踪PUBMED十大瘤种最新前沿进展,编译制作,每日分享推送,希望我们的一点点绵薄之力,能为临床助力,做医生的朋友,做患者的帮助!
目录
相关文章推荐
锦缎  ·  巴菲特2025年股东信千字脱水版 ·  14 小时前  
赋青春  ·  【红色故里】之六十四 | ... ·  3 天前  
企业专利观察  ·  说明书修改超范围,专利局认定专利继续维持有效 ·  2 天前  
企业专利观察  ·  说明书修改超范围,专利局认定专利继续维持有效 ·  2 天前  
知识产权那点事  ·  《哪吒2》票房破百亿,仅是一个开始:超级IP ... ·  4 天前  
51好读  ›  专栏  ›  毕凯今选

【其他高分选 076】

毕凯今选  · 公众号  ·  · 2024-11-21 15:06

正文

BC

PMID: 39551726

IF:27.7

Uncovering the predictive and immunomodulatory potential of transient receptor potential melastatin family-related CCNE1 in pan-cancer


SCI:Mol Cancer

PMID:39555704

IF:14.3

Precise HER2 Protein Degradation via Peptide-Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy


SCI:Adv Sci (Weinh)

PMID:39552584

IF:11.7

Mitochondrial elongation impairs breast cancer metastasis


SCI:Sci Adv

PMID:39557612

IF:16.1

Rapid, Non-Invasive, Accurate Diagnosis and Efficient Clearance of Metastatic Lymph Nodes


SCI:Angew Chem Int Ed Engl

PMID:39557820

IF:14.7

Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors


SCI:Nat Commun

PMID:39558215

IF:10.4

Integrated single-cell analysis reveals distinct epigenetic-regulated cancer cell states and a heterogeneity-guided core signature in tamoxifen-resistant breast cancer


SCI:Genome Med

PMID:39560480

IF:12.1

Deep Learning Algorithms for Breast Cancer Detection in a UK Screening Cohort: As Stand-alone Readers and Combined with Human Readers


SCI:Radiology

PMID:39558766

IF:13

EGCG-enabled Deep Tumor Penetration of Phosphatase and Acidity Dual-responsive Nanotherapeutics for Combinatory Therapy of Breast Cancer


SCI:Small

PMID:39563370

IF:11.4

METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer


SCI:J Exp Clin Cancer Res



CRC

PMID:39556364

IF:22.5

Next-Generation Multitarget Stool DNA vs Fecal Immunochemical Test in Colorectal Cancer Screening


SCI:JAMA Intern Med

PMID:39556347

IF:22.5

Is the Multitarget Stool DNA Test Just a Better "FIT" for Colorectal Cancer Screening?


SCI:JAMA Intern Med

PMID:39554798

IF:10.7

The tissue and circulating cell-free DNA-derived genetic landscape of premalignant colorectal lesions and its application for early diagnosis of colorectal cancer


SCI:MedComm (2020)

PMID:39557863

IF:14.7

IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells


SCI:Nat Commun

PMID:39557059

IF:41.6

The current and future global burden of cancer among adolescents and young adults: a population-based study


SCI:Lancet Oncol

PMID:39558030

IF:81.1

Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm


SCI:Nat Rev Clin Oncol

PMID:39558480

IF:12.2

Microbiota-derived small molecule genotoxins: host interactions and ecological impact in the gut ecosystem


SCI:Gut Microbes

PMID:39560161

IF:14.3

Sustained Endocytosis Inhibition via Locally-Injected Drug-Eluting Hydrogel Improves ADCC-Mediated Antibody Therapy in Colorectal Cancer


SCI:Adv Sci (Weinh)

PMID:39562049

IF:23

Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long non-coding transcriptome


SCI:Gut



GC

PMID:39556695

IF:14.3

Transcriptomics-Based Liquid Biopsy for Early Detection of Recurrence in Locally Advanced Gastric Cancer


SCI:Adv Sci (Weinh)

PMID:39557057

IF:41.6

Early switch maintenance in gastric cancer: who benefits most?


SCI:Lancet Oncol

PMID:39565874

IF:15.8

NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer


SCI:Sci Transl Medt



HCC

PMID:39551842

IF:14.7

Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver


SCI:Nat Commun

PMID:39560477

IF:12.1

Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma


SCI:Radiology

PMID:39563427

IF:11.4

The prognostic role of ACSL4 in postoperative adjuvant TACE-treated HCC: implications for therapeutic response and mechanistic insights


SCI:J Exp Clin Cancer Res



LC

PMID:39551792

IF:11.4

S1PR1 suppresses lung adenocarcinoma progression through p-STAT1/miR-30c-5 p/FOXA1 pathway


SCI:J Exp Clin Cancer Res

PMID:39551068

IF:41.6

Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study


SCI:Lancet Onco

PMID: 39555714







请到「今天看啥」查看全文